• 고려인삼학회:학술대회논문집
• /
• 고려인삼학회 1990년도 Proceedings of International Symposium on Korean Ginseng, 1990, Seoul, Korea
• /
• pp.68-70
• /
• 1990

• Journal of Ginseng Research
• /
• 제14권2호
• /
• pp.229-236
• /
• 1990

• 대한예방한의학회지
• /
• 제24권2호
• /
• pp.1-15
• /
• 2020

Objectives : The objectives of this study were to investigate why and how China used traditional Chinese medicine as a response to COVID-19 and how its performance was achieved, and to explore ways to utilize traditional Korean medicine in Korea. Methods : We examined the information through government data and media articles. China's COVID-19 progress and policy response were reviewed and compared with Korea. Based on this, the characteristics of traditional Chinese medicine response in China were identified. Results : Based on legal basis, China makes the overall use of traditional Chinese medicines to respond to COVID-19. Traditional Chinese medicine has been applied to health insurance, the licensing regulations have been eased, and traditional Chinese medical specialists were dispatched. The medical care guidelines were developed and R&D were carried out. In addition, policies related to traditional Chinese medicine included policies for preventive treatment, the combination of Chinese and Western medicine, and telemedicine. Conclusions : Traditional Chinese medicine response to COVID-19 was included within the overall national quarantine policy, providing medical services for the mild stage. In addition, R&D was conducted to establish a basis for the utilization of traditional Chinese medicines. Traditional Korean medicine also needs to be prepared so that it can be used as a complement to the response of communicable diseases.

• 기술혁신학회지
• /
• 제17권2호
• /
• pp.421-447
• /
• 2014

전통의학이 국가 의료체계에 편입되어 있는 국가는 한국 중국 대만 등이나 한국과 중국이 대표적이다. 본 연구는 두 나라의 전통의학 정책을 비교한 것이다. 이를 위해 전통의학 정책의 분석 틀을 최초로 제시했다. 한의학과 중의학의 공통점은 발전과정이 국가정책에 의해 규정되었고, 동일한 패턴을 보인다는 점이다. 차이점은 국가의료체계의 차이 혹은 발전정도에 따른 것이다. 중의학은 의료체계상 보다 활성화되어 있고, 중의, 중서결합의 및 민족의학까지를 다루어 범주가 크다. 한국은 저출산, 고령사회에서의 역할을, 중국은 응급 및 중대질병의 예방치료체계 구축에 관심이 크다. 한국은 해외환자 유치를 추진하고, 중국은 해외진출을 도모한다. 한국은 한약재 유통과 안전성을 강조하고, 중국은 생산기술을 강조한다. 한국은 의료기기 육성정책이 시도되고 있으나 중국은 연구개발 단계이다. 양국 공통으로 천연물 신약개발을 강조하나, 한국은 응용산업에서 한방화장품을 강조하고, 중국은 응용산업정책이 약하다. 중국은 전통의학의 문화와 이론을 강화하고 있으나 한국은 이러한 정책은 없다. 한국은 국제기구와 의료봉사에 초점을 맞추고, 중국은 국가 간 실질협력에 관심을 두고 있다.

• 한국한의학연구원논문집
• /
• 제13권3호
• /
• pp.179-184
• /
• 2007

Yifangleiju is a collection of medical books that consists of 266 volumes. It is a very important set of data in studying ancient Asian medicine because it systematically organized the many medicine-related data of Eastern Asia. But it was never published again after its 30th volume was published in 1477, and only a single copy remains in Japan today. Because this book is valuable it has been republished in China based on the copy in Japan. This study is a study of the many problems that occurred in the process of republishing Yifangleiju in China.

• 대한예방한의학회지
• /
• 제17권1호
• /
• pp.137-147
• /
• 2013

Objectives : This study aims to report current trend of Mibyeong health policy and service in China from interview of China Technology Research Group. Methods : China Technology Research Group visited Guanganmen hospital, Yanhuang Dongfang Company, Xinjingzhen health center, and Shanghai Shuguang hospital. With an interpreter, We had interviews about Mibyeong health service and policy trend, medical instrument, and research issue. Results :Mibyeong health service was performed based on KY3H system and collaboration with traditional Chinese medicine hospital. Mibyeong health service consists of diagnosis with nine constitutional type, health guide and preventive treatment. Community health center also provide Mibyeong health service, with cooperative treatment of traditional Chinese medicine and western medicine. China's Mibyeong health policy is established by Top-down decision, even though there is not enough evidence for providing health service to consumer. Through constitutional diagnosis, examinations, and treatment, huge data have been stacked; however, assessment and research based on these data are not processed well. Cooperative treatment of traditional Chinese medicine and western medicine is widely provided to patients, and their works are relatively well classified. Conclusions : China plays leading role in Mibyeong service and it seems to be developed more than Korea's. Further study is necessary to establish Mibyeong policy and health service in Korea.

• 대한한방내과학회지
• /
• 제33권2호
• /
• pp.111-125
• /
• 2012

Objectives : One of the fundamental premises of medical anthropology is the interconnectedness of medicine and society. Recent ethnographies of medicine demonstrate that the interconnectedness of the social and the medical not just evokes relatedness of the two parties, but also emphasizes the agency of the constituents, mutually shaping and being shaped. Against this backdrop, this study attempts to anthropologically investigate Korean medicine in South Korea and traditional Chinese medicine (TCM) in China. Methods : The findings are based on anthropological studies of East Asian medicine employing long-term fieldwork about Korean Medicine and Traditional Chinese Medicine. Results : TCM is characterized by standardization, hospitalization, and scientization, by which simplification, collectivization, and biomedicalization prevail in contemporary traditional medicine in China. In contrast, Korean medicine is characterized by diversity, care delivery by individual private clinics, and a considerable distance from biomedicine. To understand the divergence of the two East Asian medicines, one should consider the social contexts intervening into the medical contents, such as the role of the state and dominant discourses in given historical periods. Conclusions : Korean medicine in South Korea and TCM in China demonstrate well the hybridity of the social and the medical, suggesting that, for more comprehensive understanding of the medical, the social should be paid attention to.

• 대한예방한의학회지
• /
• 제18권1호
• /
• pp.67-82
• /
• 2014

Objective : To find a treatment strategy, this study aimed to review and compare the clinical studies of Korea, China, and Japan on traditional medicine treatment for Behcet's disease. Method : Literature searches were performed on six databases in each country and English databases, such as OASIS, KoreanTK, CNKI, J-STAGE, PubMed, and Cochrane CENTRAL. In addition, using the limited keywords, the area was restricted to traditional medicine treatment, but the period was not limited. Studies were categorized according to the study design and we analyzed the difference of treatment among three countries. Results : One hundred and forty-one clinical studies met our inclusion criteria: 11 studies in Korea, 15 in Japan, 115 in China. Randomized controlled trials (RCT) have increased in China, however, no RCT was reported in Korea and Japan. The method of treatment was mainly traditional herbal medicine in all the three countries, but there were significant differences in the field of syndrome identification and prescription among countries. The studies in China made use of most various treatment modalities and reported the highest effectiveness. Conclusion : Traditional medicine treatment showed a considerable effect for improving various symptoms of Behcet's disease. However, more research for answering the safety and well-designed studies considering characteristics of Behcet's disease should be performed to evaluate the effectiveness of traditional medicine treatment objectively in the future.

• Journal of Ginseng Research
• /
• 제45권6호
• /
• pp.617-630
• /
• 2021

Chemotherapy-induced side effects affect the quality of life and efficacy of treatment of cancer patients. Current approaches for treating the side effects of chemotherapy are poorly effective and may cause numerous harmful side effects. Therefore, developing new and effective drugs derived from natural nontoxic compounds for the treatment of chemotherapy-induced side effects is necessary. Experiments in vivo and in vitro indicate that Panax ginseng (PG) and its ginsenosides are undoubtedly non-toxic and effective options for the treatment of chemotherapy-induced side effects, such as nephrotoxicity, hepatotoxicity, cardiotoxicity, immunotoxicity, and hematopoietic inhibition. The mechanism focus on anti-oxidation, anti-inflammation, and anti-apoptosis, as well as the modulation of signaling pathways, such as nuclear factor erythroid-2 related factor 2 (Nrf2)/heme oxygenase-1 (HO-1), P62/keap1/Nrf2, c-jun Nterminal kinase (JNK)/P53/caspase 3, mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinases (ERK), AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR), mitogen-activated protein kinase kinase 4 (MKK4)/JNK, and phosphatidylinositol 3-kinase (PI3K)/AKT. Since a systemic review of the effect and mechanism of PG and its ginsenosides on chemotherapy-induced side effects has not yet been published, we provide a comprehensive summarization with this aim and shed light on the future research of PG.

• 대한한의학회지
• /
• 제29권4호
• /
• pp.13-29
• /
• 2008

Because of the changes of a variety of aspects of disease theory alternative to standard medicine, demand for traditional medicine has increased. This study was undertaken to grasp and compare traditional-medicine administrative structure, functions and role between Korea and China. According to our research, both nations promote policy related to traditional-medicine, yet there are various differences because of each nation's scale, political structure, medical system, etc. Especially, compare to the Korean government, the Chinese government not only has paid more attention to traditional medicine but also established and promoted a synthesis development strategy for a long time. Additionally, there is weakness in Korea's traditional medicine policy compared to the Chinese's Synthetic development-strategy, which is the Oriental-policy Department and Korea Food&Drug administration. Therefore, to make up for the weakness, they will have to organize their role better and make a long-term development-strategy plan for traditional medicine.